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Abstract
Tetanus and diphtheria vaccines are of special concern in adolescents
because boosters are necessary for adequate maintenance of protec-
tion and are often omitted. We assessed serum levels of tetanus and
diphtheria antibodies in adolescents and their association with vacci-
nation status. From May to October 2001, we evaluated the vaccina-
tion records of 208 adolescents aged 10 to 20 years in São Paulo,
Brazil. Antibodies to tetanus and diphtheria were detected using
double-antigen ELISA and vaccination records were analyzed accord-
ing to the guidelines of the Brazilian National Immunization Program.
All adolescents had received complete primary vaccinations against
tetanus and diphtheria, but 23.1% of them had not received a booster
dose in the last 10 years. All adolescents were immune to tetanus and
88.9% were fully protected (antibodies ≥0.1 IU/mL). One individual
(0.5%) was non-immune to diphtheria and 86% were fully protected
against the disease. Adolescents with up-to-date vaccination records
had higher antibody levels than those with not up-to-date records for
tetanus (0.763 vs 0.239 IU/mL, t-test: P < 0.0001) and diphtheria
(0.366 vs 0.233 IU/mL, t-test: P = 0.014). Full immunity against
tetanus (antibodies ≥0.1 IU/mL) was higher among individuals with
up-to-date vaccination (93.1%) when compared to those with not up-
to-date records (75%, Fisher’s exact test: P = 0.001). All adolescents
had received basic immunization in childhood and were protected
against tetanus and diphtheria. However, these data indicate that more
emphasis should be placed on the tetanus-diphtheria booster in order
to avoid a decay in antibody levels.
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Age groups other than children are being
targeted for vaccination worldwide (1). The
priority of the National Immunization Pro-
gram, when it was established in Brazil in
1973, was the vaccination of children (2).
With the gradual elimination and control of
many vaccine-preventable diseases in in-
fancy, interest in immunization has been
extended to other age groups, including ado-
lescents (2).
Tetanus and diphtheria vaccines are of
special interest because boosters are neces-
sary for the adequate maintenance of protec-
tion. Both diseases are presently under con-
trol in Brazil, with a large reduction in the
number of cases and deaths over the last two
decades (3). However, the epidemic of diph-
theria that occurred during the 1990’s in the
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Newly Independent States of the former So-
viet Union, with a high proportion of cases
amongst adolescents, highlights the neces-
sity for a periodic surveillance of immunity
against the disease (4,5).
In the present study, we evaluated the
diphtheria and tetanus vaccination and anti-
body levels against both diseases in adoles-
cents. The protocol was approved by the
Ethics Committee of the Federal University
of São Paulo, São Paulo, SP, Brazil, and
written informed consent was obtained from
parents or guardians before enrollment.
From May to the beginning of October
2001, subjects aged 10 to 20 years were
evaluated at the Adolescent Outpatient Clinic
of the Federal University of São Paulo. We
obtained 208 (82.2%) vaccination records
from a total of 253 recruited adolescents.
Each volunteer participant completed a ques-
tionnaire with information on date of birth,
age, sex, and previous immunizations and a
blood sample was collected.
Vaccines and dates of administration were
recorded and the immunization status was
evaluated according to the Brazilian Na-
tional Immunization Program, correspond-
ing to the period when the individuals were
immunized. The up-to-date immunization
records, starting from early infancy, should
have included at least three basic doses of
diphtheria-tetanus-pertussis vaccine (DTP),
a booster dose 6 months after the last dose,
with subsequent tetanus-diphtheria (Td)
booster doses every ten years.
Serum was separated and stored at -80ºC
until tested for antibody levels at the Research
Laboratory of the Division of Pediatric Infec-
tious Diseases of the Federal University of
São Paulo. Antibodies against diphtheria and
tetanus were measured by an in-house double-
antigen ELISA developed by Kristiansen et al.
(6). The double-antigen immunoassay for the
detection and quantification of anti-tetanus
and anti-diphtheria antibodies in serum showed
good correlations with established toxin neu-
tralizing assays (R = 0.960 for tetanus, and R =
0.923 for diphtheria). Different from that ob-
served when the indirect ELISA is used (which
grossly overestimates sera with anti-tetanus
and anti-diphtheria antibodies below 0.2 IU/
mL), double-antigen ELISA has a good corre-
lation also for low-titer sera (<0.1 IU/mL) (6).
A high correlation of the results of double-
antigen ELISA and neutralization assays was
also found in a study performed by the Euro-
pean Sero-Epidemiology Network (7).
For tetanus antibodies, a 96-microtiter plate
(Nunc, Kamstrup, Denmark) was coated with
0.08 µg/mL of tetanus toxoid (Butantan Insti-
tute, São Paulo, SP, Brazil) diluted in 0.1 M
carbonate-bicarbonate buffer, pH 9.6, and was
incubated overnight at 4oC. Two-fold serial
dilutions of serum samples and of reference
tetanus serum (in-house standard calibrated
against tetanus antitoxin human immunoglo-
bulin NIBSC reagent 1976 (76/589), Potters
Bar, UK) in dilution buffer (10 mM PBS, pH
7.2, 1% Triton X-100) with 1% bovine serum
albumin (Amersham, San Francisco, CA,
USA) were added to the plate and incubated
for 1 h at 37ºC. Biotin-labeled tetanus toxoid
in dilution buffer was then added to the plate
and incubated for 1 h at 37ºC. Streptavidin-
alkaline phosphatase conjugate (Zymed, San
Francisco, CA, USA) in dilution buffer was
incubated for 1 h at 37ºC. In the next step, p-
nitrophenyl-phosphate (Sigma, St. Louis, MO,
USA) in 1 M diethanolamine, 5 mM magne-
sium chloride buffer, pH 9.8, was used as a
substrate and absorbance was read at 405 and
630 nm with an immunoreader ELX-800 (Bio-
Tek Instruments, Winooski, VT, USA). The
plate was washed five times in dilution buffer
between steps.
The same method was applied for the
diphtheria antibodies, with some modifica-
tions: 0.05 µg/mL diphtheria toxoid (Butan-
tan Institute), reference diphtheria serum (in-
house standard calibrated against diphtheria
antitoxin human serum 91/534, NIBSC re-
agent) and biotin-labeled diphtheria toxoid
were used as substitutes for the correspond-
ing tetanus reagents.
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Tetanus and diphtheria antibodies are
reported as IU/mL using the curve compari-
son method to transform absorbance to con-
centration units.
Adolescents were classified into catego-
ries of immunity to tetanus and diphtheria
according to internationally accepted crite-
ria (7-10). Individuals with antibody con-
centrations of 0.1 IU/mL or more were con-
sidered to be fully protected and individuals
with levels below 0.01 IU/mL were consid-
ered to be non-immune. Those with anti-
body levels of 0.01 IU/mL or higher and
lower than 0.1 IU/mL were classified as
having basic protection. Antibody concen-
trations ≥0.01 and <0.1 IU/mL protect most
individuals against the disease, but are usu-
ally considered to represent short-term pro-
tection. Protection against the disease also
depends on the general immune status of the
individual, the dose of bacilli and the amount
of toxin produced (8,9).
Statistical analysis was carried out using
the MINITAB 10 and STATA 7.0 programs.
Geometric means were produced from raw
data. Serum antibody levels were compared
between groups by the Student t-test. Values
were submitted to logarithmic transforma-
tion before analysis due to non-normal dis-
tribution. The chi-square test and the Fisher
exact test were employed to evaluate pos-
sible association between groups and vari-
ables.
Of the 208 adolescents who had immuni-
zation cards, 61.5% were females and 38.5%,
males. Age ranged from 10.4 to 19.9 years
(mean: 14.7 years; median: 14.5 years). Ac-
cording to the National Immunization Pro-
gram schedule, 160 of them (76.9%) had an
up-to-date card and 48 (23.1%) had not up-
to-date records. Of the 48 subjects with not
up-to-date immunization records, two had
not received the DTP booster or the subse-
quent Td booster. Td booster records were
missing from all of the other 46 cards.
All adolescents were immune to tetanus:
185 (88.9%) were classified as having full
protection and 23 (11.1%) as having basic
protection. For diphtheria, only 1 adolescent
(0.5%) was non-immune, 28 (13.5%) had
basic protection, and 179 (86.0%) were fully
protected.
We analyzed the relationship between
categories of immunity and immunization
status. For tetanus, 93.1% of the adolescents
with up-to-date immunization were fully pro-
tected; in contrast, those with not up-to-date
cards were fully protected in 75.0% of cases
(Fisher’s exact test: P = 0.001; Figure 1).
For diphtheria, no statistical difference
was found between subjects with up-to-date
and not up-to-date immunization records
(Fisher’s exact test: P = 0.716). Eighty-five
percent of adolescents with up-to-date im-
munization cards were fully protected, 14.4%
had basic protection and one person (0.6%)
was non-immune to diphtheria; 89.6% of
adolescents with not up-to-date records had
full protection and 10.4% had basic protec-
tion against diphtheria (Figure 1).
Adolescents with up-to-date tetanus
Figure 1. Immunity to tetanus
and diphtheria in adolescents as
a function of vaccination status.
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tively; t-test, P < 0.001) and diphtheria (0.477
vs 0.246, respectively; t-test, P = 0.003),
probably reflecting the effect of the Td
booster dose.
Awareness of the need to vaccinate ado-
lescents is increasing (1). Many studies have
shown that immunity to diseases that need
booster vaccine doses starts to decline in
adolescence and early adulthood (11-14).
In the present study, we have shown that
more than 82% of the adolescents surveyed
had kept their vaccination cards. Pachon et
al. (12) have also found that among Spanish
children and adolescents, failure to produce
vaccination cards was more prevalent in the
10-12-year age group than in the 2-10-year
age group. In Greece, health charts were
obtained from 79% of the individuals aged
15-19 years (13).
Most of the adolescents who produced
vaccination cards were up-to-date, but 23.1%
had missed tetanus and diphtheria booster
doses. Lower statistics regarding booster
doses have been recorded in other countries.
In Spain, while primary vaccine series cov-
erage was high, 62 to 83% of adolescents
had not received a tetanus booster at 14
years of age (12). In Greece, the vaccination
rate for adolescents was 65% for tetanus and
only 54.4% for diphtheria (13). Likewise, in
Berlin only 59% of 2079 blood donors re-
ported that they had been vaccinated against
tetanus in the previous 10 years. For diph-
theria, the rate was even lower, 17% (10).
According to a national survey in the United
States, 65% of individuals aged 18 to 49
years reported having been immunized
against tetanus in the last ten years, and the
proportion decreased to 40% among those
aged 65 years or more (15).
The analysis of tetanus and diphtheria
antibodies in adolescents mirrored their vac-
cination status as assessed by their immuni-
zation records. Those with up-to-date vacci-
nations against tetanus and diphtheria had
higher antibody concentrations. When ado-
lescents were divided into categories of im-
records had higher geometric mean anti-
body levels (0.763 IU/mL, 95% confidence
interval - CI: 0.595-0.979) than those with
not up-to-date records (0.239 IU/mL, 95%
CI: 0.172-0.332; Student t-test: P < 0.0001;
Figure 2).
Similarly, diphtheria geometric mean
antibody levels were higher in adolescents
with up-to-date immunization (0.366 IU/mL,
95% CI: 0.295-0.454) than in those without
up-to-date immunization (0.233 IU/mL, 95%
CI: 0.174-0.311; Student t-test: P = 0.014;
Figure 2).
It is important to point out that geometric
mean tetanus antibody levels were signifi-
cantly higher than diphtheria antibodies
(0.584 vs 0.330 IU/mL, respectively; paired
Student t-test: P = 0.0001). No gender differ-
ences were noted for levels of tetanus anti-
bodies (males: 0.539, females: 0.614; t-test,
P = 0.556) or for diphtheria antibodies (males:
0.323, females: 0.334; t-test, P = 0.873).
However, adolescents older than 15 years
had higher antibody levels than those younger
than 15 for tetanus (0.972 vs 0.390, respec-
Figure 2. Logarithmic scale of
tetanus and diphtheria antibody
levels in adolescents with up-to-
date and not up-to-date immuni-
zation. Horizontal lines in box
plots indicate the 25th, 50th, and
75th percentiles; top and bottom
vertical lines mark extreme val-
ues and, when present, aster-
isks represent outlying values. P
values compare antibody levels
for tetanus and diphtheria in
groups with up-to-date to not up-
to-date immunization (Student t-
test).
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munity, more individuals with up-to-date vac-
cination cards were found to be fully protected
against tetanus. These findings confirm that,
as age progresses, a person’s susceptibility to
tetanus and diphtheria increases if booster
doses are omitted (8,9,14,16-19).
As also observed in other countries, many
Brazilian adolescents from São Paulo, al-
though fully vaccinated during infancy, tend
to miss their Td vaccine booster doses (12,
13), leading to a clear decay in diphtheria
and tetanus antibody levels.
Because tetanus and diphtheria vaccines
have excellent efficacy records (8,9), efforts
should be directed at adolescents and par-
ents to encourage a better vaccination cover-
age for this age group.
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